NIH to Fund Age-related Signaling Network Studies | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Institutes of Health will fund two-year grants to researchers aiming to identify novel targets within the mammalian target of rapamycin (mTOR) signaling network, which potentially could be used to promote healthy aging and extend health into old age.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.